Atlas Trials

Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

Clinical trial NCT06176456 · UNKNOWN

Trial details

NCT number
NCT06176456
Sponsor
Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CatatoniaSchizophreniaSchizo Affective DisorderBipolar Affective Disorder
Start date
2023-11-01
Primary completion
2024-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.